NTCOC
IMGN

Northern Trust Company of Connecticut’s Immunogen Inc IMGN Stock Holding History

Northern Trust Company of Connecticut’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$572K Sell
38,990
-2,570
-6% -$39.5K ﹤0.01% 1530
2013
Q3 		$707K Sell
41,560
-2,900
-7% -$51K ﹤0.01% 1443
2013
Q2 		$738K Buy
+44,460
New +$721K 0.01% 1387

Other funds holding IMGN

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Company of Connecticut's IMGN Position: Q4 2013 in Review

Northern Trust Company of Connecticut reduced its Immunogen Inc (IMGN) stake by 6.2% in Q4 2013, selling an estimated $39.5K and leaving 38,990 shares worth $572K. The position accounts for ﹤0.01% of the portfolio, ranked #1530.

Northern Trust Company of Connecticut first reported a position in IMGN in Q2 2013 and has held it in 3 quarters since. The position peaked at $738K in Q2 2013. 135 funds tracked by Wall St. Rank hold IMGN as of Q4 2013.

  • Northern Trust Company of Connecticut held 38,990 shares of Immunogen Inc worth $572K as of Q4 2013.
  • Northern Trust Company of Connecticut sold 2,570 Immunogen Inc shares in Q4 2013, an estimated $39.5K.
  • Immunogen Inc made up ﹤0.01% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #1530 holding.
  • Northern Trust Company of Connecticut first reported a position in Immunogen Inc in Q2 2013 and has held it in 3 quarters since.
  • Northern Trust Company of Connecticut's Immunogen Inc position peaked at $738K in Q2 2013.
  • 135 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.